By Jillian Foglesong Stabile MD, FAAFP, DABOM
Table of contents
- Introduction
- Overview of acute myeloid leukemia
- Recognizing the final stages of AML
- Understanding the end-of-life process in AML
- Medical and emotional care during the final stages
- Preparing for end-of-life: practical and legal considerations
- Coping strategies for families and caregivers
- FAQs
- Blood Cancer United research impact
- Conclusion
- References
Key Takeaways
- Late-stage AML is difficult to treat and typically carries a poor prognosis, with survival often measured in months.
- As the disease advances, the bone marrow can no longer produce healthy blood cells, leading to severe infections, bleeding, anemia, and potential organ failure.
- End-of-life care focuses on comfort, symptom management, and maintaining quality of life, often involving palliative or hospice care.
- Open, ongoing communication with healthcare providers and family members is crucial for effective decision-making and aligning care with your wishes.
- Emotional support for patients, families, and caregivers is essential; support groups and counseling can provide valuable assistance.
- Caregivers should also look after their own well-being, as the demands of caregiving can be physically and emotionally taxing.
Acute myeloid leukemia (AML) is a cancer of the bone marrow and blood that grows quickly without treatment. In AML, the bone marrow makes cells that are not fully developed, so they cannot do their normal jobs. Early diagnosis and starting treatment as soon as possible are important because AML can become life-threatening in a short time.
If you or someone you love has been told that there are no other treatment options available, you may feel scared, overwhelmed, or unsure of what comes next. Those feelings make complete sense and are common for people who receive this news.
Blood Cancer United is here to walk you through what to expect, answer your questions, and help you feel a little less alone. While late-stage AML is very hard to treat, there is still so much that can be done—to keep you comfortable, support your family, and make sure your wishes are honored.
Overview of acute myeloid leukemia
AML is considered a blood cancer and starts in the bone marrow, where blood cells are made. In AML, the bone marrow produces abnormal white blood cells that cannot do their job. These immature cells multiply quickly and take over the space needed for healthy blood cells.
As a result, you may experience symptoms such as feeling tired, bruising or bleeding easily, or getting infections more often.
AML is associated with genetic changes in the DNA of bone marrow cells. While it can occur at any age, most cases of AML occur in people over age 65 (Vakiti, 2024).
Other risk factors for AML include:
- Exposure to chemicals such as benzene
- Smoking
- History of treatment with chemotherapy or radiation
- Certain inherited syndromes (Down syndrome, Fanconi anemia, Bloom syndrome)
- Myelodysplastic syndrome
Additionally, males are at a higher risk for AML than females. AML has different subtypes and stages.
Unlike many cancers, AML is not staged by numbers. Instead, doctors describe AML stages as:
- Untreated: initial diagnosis, often greater than 20% blast cells
- Remission: no detectable disease
- Active: detectable disease (typically greater than 5% blasts) during treatment
- Relapsed: detectable disease after remission
Late-stage AML is hard to treat and usually has a poor outlook. Survival depends on your age, the genetic features of your AML, how well treatment works, and your overall health. For people with late-stage AML and high-risk features, the survival rate is about 3% (Sasaki, 2022).
The average life expectancy after late-stage diagnosis is typically measured in months rather than years, often around 3-12 months depending on treatment options and individual health factors (Miyamoto, 2022).
Recognizing the final stages of AML
As AML reaches its final stages, changes can happen quickly. Your body is working harder than ever, and you or your loved one may begin to notice new or worsening symptoms.
Knowing what to look for can help you feel more prepared and know when to reach out to your care team. Be on the lookout for symptoms like:
- Increasing infection frequency
- Severe fatigue
- Easy bruising and bleeding
- Shortness of breath
- Confusion and cognitive decline
- Bone and joint pain
You may also see physical changes such as pale skin, swollen gums, a swollen belly, and weight loss (Blood Cancer United, 2025).
Understanding the end-of-life process in AML
Knowing what to expect in the end stages of AML can help you and your family prepare for what is ahead (Alam, 2022).
As AML progresses, the body struggles to keep up. Without enough healthy blood cells, even small infections can become serious, and the body may have trouble stopping bleeding or getting enough oxygen. In time, this places strain on the heart, lungs, and other organs.
In the final stage of AML, the body gradually becomes unable to sustain itself as the bone marrow can no longer produce the blood cells it needs. This is a natural part of the disease's progression.
When AML reaches this stage, it’s common for a patient to experience severe infections, uncontrolled bleeding, organ failure, and trouble breathing. In the final stages, care focuses on comfort instead of a cure.
Final stage AML means the disease is not responding to treatment. At this point, care is focused on comfort, managing symptoms, and supporting you and your family. Palliative care and hospice teams are often involved in helping during this time.
Medical and emotional care during the final stages
If you have final stage AML, palliative care—also called supportive care—and hospice provide important support. These services focus on comfort and quality of life.
Palliative care can begin at any time during AML, even while you are still getting treatment. In the final stages, palliative care is especially important. The team helps manage symptoms, supports you and your family, explains your options, and gives practical advice for daily needs (Dohner, 2022).
Hospice care is usually considered when life expectancy is six months or less. With hospice, the focus is on comfort and managing symptoms, not on active treatment. Hospice teams are experts in controlling symptoms and providing emotional and spiritual support.
They can also help you and your family with end-of-life planning, including advance directives and funeral arrangements. Hospice care can be given at home, in the hospital, in a nursing facility, or in a hospice facility—wherever you and your family feel most comfortable.
Both palliative care and hospice help manage symptoms. This can include pain medicine, oxygen, medicines for shortness of breath, and treating infections with comfort as the main goal. They can also teach you ways to save energy so you can do gentle activities if you feel up to it. Both types of care focus on supporting you and your family emotionally as you go through the final stages of AML.
It is important to talk regularly with your healthcare team as you navigate life with AML. Open conversations help you decide when to start palliative care or hospice. These talks also help your team understand your wishes and what matters most to you.
Preparing for end-of-life: practical and legal considerations
Along with managing symptoms and providing emotional support, there are practical and legal steps to consider as you plan for end-of-life care.
Advance directives are legal documents that let you share your wishes about medical care if you cannot speak for yourself. These can include your choices about life support, CPR, and other treatments. Advance directives help your healthcare team, and let your family know what they need to do to respect your wishes.
A healthcare proxy is someone you choose to make medical decisions for you if you are unable to do so. This is also called a medical power of attorney.
As you prepare for end-of-life in the final stages of AML, talk with your family and healthcare team. These conversations help everyone understand your values and wishes in the event you are unable to advocate for yourself. You may also want to plan for hospice care if you have not already done so.
Coping strategies for families and caregivers
Caring for someone with terminal AML can be challenging, both emotionally and physically. Families and caregivers often need support as well, including ways to cope. It is normal—and completely human—to feel grief and loss even before your loved one passes away.
There’s a name for this. Anticipatory grief is the sadness or mourning you may feel before your loved one dies. Families and caregivers may grieve for the person and for the loss of shared hopes and plans. It is common to feel loss, anxiety, anger, or helplessness.
Support groups, both in person and online, can help if you are caring for someone with AML. These groups connect you with others who are going through similar experiences, and Blood Cancer United has information on support groups for families affected by blood cancers.
Caregiving can be exhausting, so it is important to take care of your own health and emotions. Make sure to rest, eat well, and ask for help or respite care when you need it. Family and friends can help with daily chores, meals, and errands. Hospice and palliative care teams can also give advice and support for the practical and emotional parts of caring for someone with terminal AML.
FAQs
What happens in the final days of acute myeloid leukemia?
In the final days of AML, your body gradually slows down and begins to rest. You may notice extreme weakness, more sleep, less appetite, shallow or irregular breathing, less urine that is darker, and cool hands and feet. These changes are a normal part of the end-of-life process (Blood Cancer United, 2025).
How long can you live in the final stages of AML?
In the final stages of AML, most people live for days to weeks, but the exact time can vary for each person (Miyamoto, 2022).
Can late-stage AML patients recover?
Recovery from late-stage AML is very rare (Sasaki, 2022). When the bone marrow is full of cancer cells, AML usually does not respond to treatment anymore. Care then focuses on comfort and quality of life. Sometimes there are short-term improvements, but these are uncommon.
Blood Cancer United research impact
Blood Cancer United is the largest global nonprofit focused on blood cancer support, research, and advocacy. Since the organization’s founding in 1949, it has funded research projects that advance blood cancer treatments.
Blood Cancer United has funded projects that have made significant progress in the treatment of AML—including the Beat AML Master Clinical Trial, PedAL, and other active research grants—with the hopes of curative therapies for all types of AML and every kind of blood cancer.
To support AML research, as well as other blood cancer research, consider donating today.
Conclusion
Facing advanced AML is difficult for you and your loved ones. Late-stage AML is rarely reversible, but knowing what to expect as care shifts from cure to comfort can help you and your family prepare both practically and emotionally.
No one should have to navigate this alone. Working closely with your healthcare team, leaning on support systems, and accessing reliable educational resources can help you make informed decisions and focus on quality of life.
For those looking to learn more about the disease, treatment advances, and ongoing scientific developments, Blood Cancer United offers a comprehensive library of AML research, educational resources, and updates on emerging therapies that may help patients and families better understand acute myeloid leukemia and the evolving landscape of care.
References
- Vakiti, Anusha, Samuel B. Reynolds, and Prerna Mewawalla. 2024. “Acute Myeloid Leukemia.” StatPearls - NCBI Bookshelf. April 27, 2024. https://www.ncbi.nlm.nih.gov/books/NBK507875/.
- Sasaki, Koji, Farhad Ravandi, Tapan Kadia, Courtney DiNardo, Gautam Borthakur, Nicholas Short, Nitin Jain, et al. 2022. “Prediction of Survival With Intensive Chemotherapy in Acute Myeloid Leukemia.” American Journal of Hematology 97 (7): 865–76. https://doi.org/10.1002/ajh.26557.
- Ag-Acnp, Meredith Beaton Rn, Msn, Glen J. Peterson Rn Acnp Dnp, and Kelly O’Brien Rn Acnp-Bc Msn, Anp-C,. 2020. “Acute Myeloid Leukemia: Advanced Practice Management From Presentation to Cure.” Journal of the Advanced Practitioner in Oncology 11 (8): 836–44. https://doi.org/10.6004/jadpro.2020.11.8.4.
- Miyamoto, Toshihiro, David Sanford, Ciprian Tomuleasa, Hui-Hua Hsiao, Leonardo José Enciso Olivera, Anoop Kumar Enjeti, Alberto Gimenez Conca, et al. 2022. “Real-world Treatment Patterns and Clinical Outcomes in Patients With AML Unfit for First-line Intensive Chemotherapy *.” Leukemia & Lymphoma/Leukemia and Lymphoma 63 (4): 928–38. https://doi.org/10.1080/10428194.2021.2002321.
- “Acute Myeloid Leukemia in Adults: In Detail | Blood Cancer United.” 2025. May 15, 2025. https://bloodcancerunited.org/resources/educational-resources/publications/booklet/acute-myeloid-leukemia-adults-detail
- Alam, Sara Taveras, Elyse Lopez, Deepa Dongarwar, Ramesh Pandey, Nataly Torrejon Guzman, and Mary Caroline Tarallo. 2022. “Acute Myeloid Leukemia Place of Death: Change Over Two Decades.” Blood 140 (Supplement 1): 11011–12. https://doi.org/10.1182/blood-2022-167570.
- Döhner, Hartmut, Andrew H. Wei, Frederick R. Appelbaum, Charles Craddock, Courtney D. DiNardo, Hervé Dombret, Benjamin L. Ebert, et al. 2022. “Diagnosis and Management of AML in Adults: 2022 Recommendations From an International Expert Panel on Behalf of the ELN.” Blood 140 (12): 1345–77. https://doi.org/10.1182/blood.2022016867.
